Hold BKNG with $162 put hedge; fundamental floor intact ($17.2B cash, 0.28× net leverage, $9B FCF), two-of-four triggers for re-engagement, hard stop at $158, Q3 earnings as binary event.
Hold BKNG with protective put hedge ($162 strike, ~5% OTM, 4-6 week expiry). Override Research Manager's Underweight and Trader's Sell because two consecutive UW tilts (9/11, 9/9) failed at this exact setup (+1.3% and +1.1% alpha respectively), and the fundamental floor is intact ($17.2B cash, 0.28× net leverage, $9B FCF, 0.65 PEG, $10.1B deferred revenue, Q2 record print). Re-engagement requires two of four triggers (not three): 200 SMA reclaim above $184, MACD histogram contracts toward -2.0, RSI curls above 35, OR oil retraces below $95. Hard stop at $158. Q3 earnings late October/early November is binary resolution event — beat-and-raise forces Overweight; guide-down forces Underweight reassessment.
| Position | Action |
|---|---|
| Default state | Maintain benchmark weight with protective put hedge (~$162 strike, ~5% OTM, 4-6 week expiry, ~30-50 bps annual yield cost) |
| Two of four triggers met (200 SMA reclaim above $184, MACD histogram contracts toward -2.0, RSI curls above 35, OR oil retraces below $95) | Re-engage with Overweight positioning |
| Price breaches $158 | Hard stop triggered — exit position |
BKNG's 20% selloff to $171 presents a tactical accumulation opportunity in a fundamentally fortress business trading at value-stock multiples, supported by oversold technicals, strong Q2 results ($1.95B net income), and Morgan Stanley's top OTA pick rating.
| Indicator | Value | Signal |
|---|---|---|
| Close | 171.40 | neutral |
| Open | 171.34 | neutral |
| High | 173.69 | neutral |
| Low | 170.04 | neutral |
| Volume | 5,982,773 | neutral |
| 10 EMA | 179.92 | bearish |
| 50 SMA | 192.77 | bearish |
| 200 SMA | 184.34 | bearish |
| 20 SMA (Bollinger Middle) | 193.59 | bearish |
| Bollinger Upper Band | 225.37 | neutral |
| Bollinger Lower Band | 161.82 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Histogram contracts toward -2.0
Then: Second of two required triggers for re-engagement
↩ rebuts: “EU blocked ETraveli deal as fatal blow thesis”
EV: +30-44% (to $223-$247 at 18-20x forward P/E on $12.37 EPS) · concedes: Oil above $105 squeezes lower-income consumer cohort that travels; RSI oversold conditions can persist longer than expected in bear markets; Hawkish Fed and geopolitical risks (Middle East conflict) created short-term demand pause in June
BKNG faces a macro-driven punishment scenario where hawkish Fed policy, oil at $105, and consumer stress will overwhelm fundamental strength, compressing multiples and sending the stock toward $117-$140s until technical signals stabilize and macro conditions improve.
· concedes: BKNG is a fundamentally strong franchise; Balance sheet is a fortress; Buybacks are aggressive and cash flow is elite; Q2 underlying business improvement was meaningful (15-20% YoY operating profit growth)
→ vs conservative: The 'wait for confirmation' thesis means buying at $194 after the 20 SMA is reclaimed, which is buying high
→ vs conservative: RSI at 29.84 near lower Bollinger band at $161.82 are textbook mean-reversion setups, not reasons to stay sidelined
→ vs neutral: Treating uncertainty as a reason for inaction creates opportunity cost compounded over time
→ vs neutral: A business with 34.4% operating margins, 20.4% ROA, and 0.28x Net Debt/EBITDA at 13.85x forward earnings has overwhelming asymmetry to the upside
→ vs aggressive: The trader's $158 stop is only 8% below current levels and is a high-probability stop-out right before reversion given oversold conditions
→ vs aggressive: The 'three of four triggers' re-entry plan is paralysis dressed up as discipline that will cause investors to miss the move
→ vs aggressive: MACD at -3.45 with RSI brushing 30 is a momentum climax, not a reason to add shorts - every major bottom features this configuration
| neutral |
| MACD Line | -7.45 | bearish |
| MACD Signal | -4.00 | bearish |
| MACD Histogram | -3.45 | bearish |
| RSI (14-period) | 29.84 | bearish |
| ATR (14-period) | 6.65 | neutral |
Support: 161.82 · 170.04 | Resistance: 179.92 · 184.34 · 192.77 · 193.59
BKNG has transitioned from a strong uptrend in early August into a sharp, sustained downtrend, collapsing from peak closes around $213.26 to $171.40 by 2026-09-16 — a drawdown of approximately 20%. All three moving averages are stacked bearishly (10 EMA < 50 SMA < 200 SMA), MACD is deeply negative with an expanding histogram at −3.45, and RSI has printed 29.84, sitting just above the 30 oversold threshold. Price is pressing toward the lower Bollinger Band at $161.82; a decisive break below would likely accelerate selling. The overall rating is HOLD — the dominant downtrend argues against adding long exposure, but the oversold RSI and proximity to the lower band make this an unattractive fresh-short entry as well. New capital is best kept on the sidelines until the 20 SMA at $193.59 is reclaimed on a closing basis.
Market Cap
$128.79 B
TTM P/E
19.07x
Forward P/E
13.85x
PEG Ratio
0.65
Price/Book
-12.05x
EPS (TTM)
$8.99
Forward EPS
$12.37
Beta
1.068
52-Week High
$224.99
52-Week Low
$150.14
Revenue FY2025 ($M)
26,917
Operating Income FY2025 ($M)
9,282
EBITDA FY2025 ($M)
9,217
Net Income FY2025 ($M)
5,404
Diluted EPS FY2025
$6.62
Operating Margin (TTM)
34.4%
Net Margin (TTM)
25.5%
Return on Assets (TTM)
20.4%
FCF Margin (TTM)
~27%
Cash & ST Investments Q2'26 ($M)
17,214
Total Debt Q2'26 ($M)
20,694
Net Debt Q2'26 ($M)
2,966
Net Debt / EBITDA
~0.28x
Stockholders' Equity Q2'26 ($M)
-10,783
Treasury Stock Q2'26 ($M)
62,129
Retained Earnings Q2'26 ($M)
43,046
Current Ratio Q2'26
1.09
Deferred Revenue Q2'26 ($M)
10.12 B
Operating Cash Flow FY2025 ($M)
9,409
CapEx FY2025 ($M)
322
Free Cash Flow FY2025 ($M)
9,087
Dividends Paid FY2025 ($M)
1,248
Buybacks FY2025 ($M)
6,440
Q2'26 Revenue ($M)
7,352
Q2'26 Operating Income ($M)
2,500
Q2'26 Net Income ($M)
1,950
Q2'26 Diluted EPS
$2.53
Diluted Shares Q2'26 (M)
758
Revenue CAGR 2022-2025
+16.3%
Net Income CAGR 2022-2025
+20.9%
EPS CAGR 2022-2025
+29.4%
Strengths
Concerns
BUY — Booking Holdings is a fundamentally elite franchise operating the world's largest OTA platform with Booking.com, Priceline, Agoda, and KAYAK. The company generates exceptional free cash flow ($9.1B in 2025) from an asset-light model with best-in-class 34.4% operating margins and 20%+ ROA. Trading at a Forward P/E of 13.85x with a 0.65 PEG ratio, the stock appears undervalued relative to its 37%+ EPS growth trajectory, with accelerating buybacks (5% share reduction in H1 2026) and a deferred revenue surge to $10.1B signaling strong H2 2026. Key risks include FX volatility, regulatory headwinds from the EU Digital Markets Act, and potential travel-cycle deceleration.
Macro: Hawkish week anchored by surprise Fed rate hike (not cut) on Sept 16, with 95% Polymarket probability of zero cuts in 2026. Oil above $105/bbl squeezing consumer discretionary budgets. 10-year Treasury below 5% but rising on Fed decision. Jamie Dimon reinforced inflation stickiness narrative. Recession odds ticking up modestly (US and UK both at 10%, +3pp). Crypto stocks sold off on CLARITY Act failure. Travel and retail stocks hitting 52-week lows per Barron's.